News from Aurigene

Jun 24, 2014, 09:09 ET
Aurigene Logo

Aurigene and Orion Corporation Announce Research, Collaboration and Option Agreement for Rights to Aurigene's Epigenetics Program for Pan BET and Selective BET Bromodomain Inhibitors

Orion Corporation, a globally operating Finnish pharmaceuticals company and Aurigene, a leading biotech company based in India, today announced...

Feb 13, 2014, 03:14 ET
Aurigene Logo

Aurigene and Pierre Fabre Pharmaceuticals Announce a Licensing Agreement for a New Cancer Therapeutic in Immuno-oncology: AUNP12, an Immune Checkpoint Modulator Targeting the PD-1 Pathway

Pierre Fabre, the third largest French pharmaceutical company, and Aurigene, a leading biotech company based in India, today announced that the...

Apr 22, 2013, 07:00 ET
Aurigene Logo

Aurigene's Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones

Aurigene and Endo entered into collaboration in 2009, for multiple integrated drug discovery programs in the areas of Inflammation and...

Apr 18, 2013, 07:00 ET
Aurigene Logo

Aurigene Announces Transition of Multiple Programs to Clinical Development in its Collaboration Business

Aurigene has had a number of collaboration programs with large pharma companies over the years, and has reported successes in these...

Apr 02, 2013, 07:00 ET
Aurigene Logo

Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013

Aurigene will be presenting poster sessions for three of its programs at the American Associate of Cancer Research (April 6-10 in Washington,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge